Emily V. Walker, Yiling Zhou, Yifan , Jiaqi Liu, Seth A. Climans, Faith G. Davis and Yan Yuan. The Incidence and Prevalence of Primary Central Nervous System (CNS) Tumours in Canada (2010–2017), and the Survival of Patients Diagnosed with CNS Tumours (2008–2017).
Liu, J.L.; Walker, E.V.;Paudel, Y.R.; Davis, F.G.; Yuan, Y. Brain Metastases among Cancer Patients Diagnosed from 2010–2017 in Canada: Incidence Proportion at
Diagnosis and Estimated Lifetime Incidence. Curr. Oncol. 2022, 29, 2091–2105.
https://doi.org/10.3390/curroncol29030169
Davis FG, Smith TR, Gittleman H, Ostrom Q, Kruchko C, Barnholtz-Sloan J. Glioblastoma Incidence in Canada and the US in Comparison with England 1995-2015 [Letter to the Editor]. Neuro-Oncology (Accepted)
Walker EV, Ross J, Yuan Y, Smith TR, Davis FG. Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics. Current Oncology. 2019;26(3):e292–e299. doi:10.3747/co.26.4273
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588061/
Walker EV, Davis FG; CBTR founding affiliates. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013. Neuro Oncol. 2019;21(3):360–369. doi:10.1093/neuonc/noy195
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380406/pdf/noy195.pdf
Eckstrand A, Shack L, Pham T, Davis F. The Impact of Hospital Discharge Linkage on Case Ascertainment of Brain Tumours in the Alberta Cancer Registry, 2010-2015. Journal of Registry Management. 2018; 45;3, 109-116.
http://www.ncra-usa.org/Portals/68/JRM%20Fall%202018%20Final.pdf?ver=2019-03-07-162810-593
Yuan Y, Amjad S , Eckstrand A, Sevick R, Scott J, Devji S, Bertrand C, King M, Brunka V, Maplethorpe E, Walker E, Muanza T, Davis FG. On Capturing Radiological Diagnoses Of Brain Tumours To Provide Complete Population Data In Cancer Registries In Canada. Journal of Registry Management. 2018; 45: 167-172
http://www.ncra-usa.org/Portals/68/JRM%20Winter%202018.pdf?ver=2019-05-10-174139-137
Yuan Y, Ross J, Shi Q, Davis FG. Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000–2008. Current Oncology. 2017; 24(5):e341-e347. doi: 10.3747/co.24.3579.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659157/pdf/conc-24-e341.pdf
Yuan Y , Shi Q , Li M , Nagamuthu C, Andres E , Davis FG. Canadian brain cancer survival rates by tumour type and region: 1992-2008. Canadian Journal of Public Health Revue Canadienne de Sante Publique. 2016; 107(1): e37 ́ -42.
Davis FG, Nagamuthu C*, Ross J* and Megyesi J. Current Status of Brain Tumour Surveillance in Canada and Why it Matters. Journal of Registry Management. 2015; 42(4):139-45.
http://www.ncra-usa.org/Portals/68/PDFs/JRM_Winter.2015_V42.4.pdf?ver=2017-07-27-152259-607
Other Relevant Publications:
Zacharia D, Shaw A, Woods R, De P, Davis F. Case-Completeness of Nonmalignant Central Nervous System Tumours in the Canadian Cancer Registry, 2011-2015. Journal of Registry Management. 2018; 45:3; 117-131.
http://www.ncra-usa.org/Portals/68/JRM%20Fall%202018%20Final.pdf?ver=2019-03-07-162810-593